Kiwa Bio-Tech Products Group Corporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 10.986 million compared to USD 7.725 million a year ago. Operating income was USD 1.852 million compared to USD 1.211 million a year ago. Net income was USD 311,217 compared to USD 623,361 a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.01 compared to USD 0.04 a year ago. For the nine months, sales was USD 31.454 million compared to USD 21.811 million a year ago. Operating income was USD 2.288 million compared to USD 1.614 million a year ago. Net loss was USD 1.543 million compared to net income of USD 40,961 a year ago. Basic loss per share from continuing operations was USD 0.08 compared to Basic EPS - Continuing Operations of USD 0 a year ago.